About Leuko
Leuko is a company based in Boston (United States) founded in 2017 by Carlos Castro Gonzalez, Alvaro Sanchez-Ferro, Aurelien Bourquard, and Ian Butterworth. Leuko has raised $6.8 million across 4 funding rounds from investors including NIH, HHS and Good Growth Capital. Leuko offers products and services including PointCheck and A.I. Algorithms.
- Total Equity Funding$6.8M (USD)
in 4 rounds
- Latest Funding Round$4.5M (USD), Grant
Jul 2024
- InvestorsNIH
& 6 more
Products & Services of Leuko
Leuko offers a comprehensive portfolio of products and services, including PointCheck and A.I. Algorithms.
A device is developed for non-invasive monitoring of white blood cell levels, intended for use in home environments to assess infection risks.
Algorithms are employed to analyze blood cell data captured by the device, aiding in the determination of elevated infection risks.
Funding Insights of Leuko
Leuko has successfully raised a total of $6.8M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $4.5 million completed in July 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.8M
- Total Rounds 4
- Last Round Grant — $4.5M
- First Round $3.96M
(Jul 2018)
- Investors Count 7
All 4 funding rounds of Leuko with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2024 | $4.5M | Grant | – | – | |
| Sep 2022 | $5M | Series A | – | – | |
| Feb 2019 | $1.8M | Seed | – | Good Growth Capital | |
| Jul 2018 | $3.96M | Grant | – | – |
7 investors in total: 7 institutional.
Investors in Leuko
Leuko has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and Good Growth Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
HTH is engaged in investing in health technology startups. | 2020 | hthvc.com | Milan, Italy | |
Early-stage investments are made in life sciences and technologies. | 2017 | goodgrowthvc.com | Charleston, United States | |
Venture capital investments are provided by IAG Capital Partners. | – | iagcapitalpartners.com | Charleston, USA | |
- | – | nina.capital | - | |
Venture capital fund investing in tech startups | – | pegasustechventures.com | San Jose, United States | |
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | - |
Investor details for Leuko
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Leuko
4 people are tracked at Leuko (4 in leadership).
| Name | Role | Group |
|---|---|---|
Carlos Castro Gonzalez | Co-Founder & CEO | Leadership |
Alvaro Sanchez-Ferro | Co-Founder | Leadership |
Aurelien Bourquard | Co-Founder | Leadership |
Ian Butterworth | Co-Founder | Leadership |
Complete people profiles for Leuko
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Leuko
3 dated milestones of Leuko across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Leuko is founded.
- Funding First funding round of $4.0M.
- Funding Latest funding round, Grant, of $4.5M.
Web traffic of Leuko
The website of Leuko (leuko.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▲ 456.6% vs previous month
Similar companies to Leuko
10 companies that operate in the same segment as Leuko (Traditional Diagnostics & Medical Devices), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Materials management solutions are provided for healthcare organizations. | 1892 | Chicago, Illinois, United States | USD 29.13 M | USD 20.63 B | 53,000 | |
3D-printed orthopedic products are manufactured for medical applications. | 1941 | Kalamazoo, Michigan, United States | – | – | – | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Heart pumps are developed for blood circulation and oxygenation support. | 1981 | Danvers, Massachusetts, United States | – | USD 1.03 B | 1,157 | |
Medical device management services are provided to healthcare facilities. | 1999 | Exeter, New Hampshire, United States | USD 275.93 M | USD 68.67 M | 353 | |
Medical surgical consumables including sutures and anti-microbial gloves are manufactured. | 1992 | Bengaluru, Karnataka, India | USD 102.36 M | USD 7.14 K | 39 | |
Manufacturer of medical equipments | 1967 | Bengaluru, Karnataka, India | USD 58.9 M | USD 98.65 M | 578 | |
BD is recognized for providing innovative medical technology solutions. | 1897 | Franklin Lakes, New Jersey, United States | – | USD 21.84 B | 74,000 | |
Dental lasers and scanning devices are developed for clinical use. | 1987 | Foothill Ranch, California, United States | – | USD 49.16 M | – | |
Manufacturer and distributor of aprons, surgical gowns, uniforms, and other medical products | 1966 | Mundelein, Illinois, United States | – | USD 28.45 B | 1,305 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Leuko
Leuko was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Leuko is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Carlos Castro Gonzalez is the current CEO of Leuko. They have also founded this company.
Leuko is a funded company, having raised a total of $6.8M across 4 funding rounds to date. The company's 1st funding round was a Grant of $3.96M, raised on Jul 2018.
Leuko was founded in 2017 and is headquartered in Boston, United States. Operations focus on the medical device sector, where a non-invasive device for monitoring white blood cell counts is developed and produced. This technology supports hematology diagnostics in healthcare settings. The company was established by co-founders including Carlos Castro Gonzalez as CEO, Alvaro Sanchez-Ferro, Aurelien Bourquard, and Ian Butterworth. Activities are centered on advancing point-of-care testing solutions. (68 words).
Leuko offers PointCheck and A.I. Algorithms.
Leuko has 7 investors. Key investors include NIH, HHS, Good Growth Capital, HTH, and IAG Capital Partners.
Leuko operates through Leuko Labs Inc.